Viridian Therapeutics (VRDN)

Viridian Therapeutics (VRDN) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• VRDN last traded at $26.25, 3.75% on the day.
• Viridian Therapeutics: P/E -7.2, revenue $71.13M over the last four quarters.
• Over the past year VRDN returned 11.09%; year to date -15.65%.

Updated 2026-11-03 12:32 UTC